M-pox vaccine in US but not in India: Doctors show concern

| Updated: 20 August, 2024 7:00 pm IST

NEW DELHI: As M-pox, previously known as Monkey Pox, emerges on India’s doorstep with the first case reported in Pakistan, the question on country’s preparedness rises. 

The virus, introduced by a patient traveling from the UAE in Pakistan, highlights India’s vulnerability and the limited infrastructure available to tackle this potential crisis. With only 32 testing labs nationwide, the country is far from ready to face a widespread outbreak. The last known case of M-Pox in India was one in March 2024 ending in a recovery.

Dr. Tushar Tayal, Lead Consultant, Department of Internal Medicine, CK Birla Hospital, Gurugram, speaking to The New Indian, shows concerns on the spread of the virus. 

He pointed out that M-pox, primarily an African virus, is a new threat to Asian countries. “The M-pox vaccine is available in the US, but India neither has a vaccine nor specific medicine. Even a minor spread in our densely populated nation could have severe consequences,” he warned.

ALSO READ: WHO calls M-pox a global crisis; Indian Doctors prepares a mid 1% to 10% fatality rate for Clade 1 – THE NEW INDIAN

The virus, though known for its initial symptoms, can be unpredictable in its progression. Dr. Tayal explained that depending on the individual, M-pox could spread to vital organs like the brain, lungs, and heart, leading to fatal outcomes.

Despite some doctors suggesting that the smallpox vaccine might offer protection, Dr. Tayal emphasises the significant differences between the two viruses. M-pox is distinguished by symptoms such as swollen lymph nodes and deeper, more extensive lesions. Procuring an adequate supply of vaccines from the US would be a really tough task for India.

The Indian government and health ministry have started to take measures by increasing the vigilance at international airports and borders close to Bangladesh and Pakistan, closely monitoring international arrivals, and giving directives on creating quarantine centres.

ALSO READ: AIIMS Delhi issues guidelines on M-Pox following WHO warning – THE NEW INDIAN

However, Dr. Tayal remains skeptical about the country’s readiness. He notes that India’s lack of experience with this virus, combined with its enormous population, presents a significant challenge. “When something new emerges, it’s difficult to prepare, especially on the scale required for a country like India,” he remarked.

But he suggests that preventive measures are always best, and they are similar to those of COVID, like wearing a mask, maintaining distance from the patient, and keeping the patient in quarantine.

Also Read Story

15 years, still no multispecialty hospital? Ravi Rane faces tough questions from Amravati, Badnera voters

Amravati’s flower sellers and vendors rally for BJP in Maharashtra Elections 2024

Maharashtra voters say Ladki Bahin Yojna aims to sway, not support

Lessons for India from Tulsi Gabbard’s approach to Trump’s win